AEON Biopharma
1.10
+0.03
+2.80%
AEON
02-06 16:10:00(美东时间)
高
1.12
开
1.06
量
73113股
总市值
2642.67万
低
1.01
换
0.30%
额
7.64万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
AEON Biopharma(AEON)
2025-11-14 21:45
$AEON Biopharma(AEON)$
10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001837607-25-000085 Act: 34 Size: 15 MB
网页链接
AEON Biopharma(AEON)
2025-11-13 21:35
$AEON Biopharma(AEON)$
8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001837607-25-000072 Act: 34 Size: 39 MB
网页链接
AEON Biopharma(AEON)
2025-11-14 05:15
$AEON Biopharma(AEON)$
DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001837607-25-000079 Act: 34 Size: 53 KB
网页链接
AEON Biopharma(AEON)
2025-12-04 22:05
$AEON Biopharma(AEON)$
8-K Current report, items 7.01 and 9.01 Accession Number: 0001837607-25-000088 Act: 34 Size: 5 MB
网页链接
AEON Biopharma(AEON)
01-30 10:05
$AEON Biopharma(AEON)$
SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001213900-26-009785 Act: 34 Size: 14 KB
网页链接
AEON Biopharma(AEON)
2025-12-20 05:05
$AEON Biopharma(AEON)$
PRE 14A Other preliminary proxy statements Accession Number: 0001837607-25-000099 Act: 34 Size: 4 MB
网页链接
AEON Biopharma(AEON)
2025-12-16 06:36
$AEON Biopharma(AEON)$
8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001837607-25-000092 Act: 34 Size: 970 KB
网页链接
AEON Biopharma(AEON)
2025-12-30 05:15
$AEON Biopharma(AEON)$
DEF 14A Other definitive proxy statements Accession Number: 0001837607-25-000104 Act: 34 Size: 4 MB
网页链接
AEON Biopharma(AEON)
2025-11-14 21:35
$AEON Biopharma(AEON)$
8-K Current report, items 2.02 and 9.01 Accession Number: 0001837607-25-000084 Act: 34 Size: 416 KB
网页链接
AEON Biopharma(AEON)
01-30 10:25
$AEON Biopharma(AEON)$
SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership Accession Number: 0001213900-26-009802 Act: 34 Size: 17 KB
网页链接
AEON Biopharma(AEON)
01-30 10:35
$AEON Biopharma(AEON)$
3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-009803 Size: 11 KB
网页链接
AEON Biopharma(AEON)
01-22 05:15
$AEON Biopharma(AEON)$
8-K Current report, items 3.02, 5.02, 5.07, 7.01, 8.01, and 9.01 Accession Number: 0001837607-26-000005 Act: 34 Size: 447 KB
网页链接
AEON Biopharma(AEON)
2025-11-14 21:45
$AEON Biopharma(AEON)$
DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001837607-25-000086 Act: 34 Size: 252 KB
网页链接
AEON Biopharma(AEON)
01-12 22:25
$AEON Biopharma(AEON)$
8-K Current report, items 7.01 and 9.01 Accession Number: 0001837607-26-000002 Act: 34 Size: 6 MB
网页链接